DKSH enters exclusive distribution agreement with Omya in France and Spain December 03, 2020


			
				DKSH enters exclusive distribution agreement with Omya in France and Spain

DKSH has signed an exclusive distribution agreement with Omya, a leading global producer of mineral-based solutions, for France and Spain.

Media release

DKSH enters exclusive distribution agreement with Omya in France and Spain

DKSH has signed an exclusive distribution agreement with Omya, a leading global producer of mineral-based solutions, for France and Spain.

Zurich, December 3, 2020 – DKSH’s Business Unit Performance Materials has become the exclusive distribution partner for Swiss-based company Omya in France and Spain. As part of the agreement, DKSH will  provide marketing and sales, distribution and logistics as well as customer management for Omya’s portfolio of nutraceutical and pharmaceutical ingredients. This partnership is in line with DKSH's strategic direction of expanding the Business Unit's leading position in specialty chemicals and ingredients distribution.

 

According to the product, the brands based on calcium carbonate (Omyapure®, Calcipur®, Calcipur® DC) can be used as Active Pharmaceutical Ingredients (API) or as excipients. In the first case, the most common application is calcium supplementation in the treatment of diseases, such as osteoporosis, osteopenia and rickets. As an API, calcium carbonate is also used as antacid in oral, solid or liquid medicines. When used as excipient, calcium carbonate either acts as a diluent or as a pH stabilizer of acid sensitive drugs.

 

The products based on Functionalized Calcium Carbonate (FCC) include the brands Omyapharm®, Omyanutra® and Omyaforte. Omyapharm® and Omyanutra® are used as excipients in the formulation of pharmaceutical and nutraceutical oral solid dosage forms, respectively. Thanks to their very unique properties, both products provide high performance in formulations, such as fast disintegration, excellent compactibility or act as carriers for transforming liquid APIs into high compactable powders. Omyaforte® is a premium highly bio-available source of elemental calcium suitable for the formulation of nutraceuticals (food supplements).

 

DKSH was entrusted to grow Omya’s business thanks to its extensive distribution network, strong service capabilities, deep technical know-how and formulation expertise and its proven track record as a strategic partner in Europe.

 

“Omya is delighted to start a strong and reliable partnership with DKSH. With their proven experience in the pharmaceutical and nutraceutical industries, DKSH will be able to offer Omya’s solutions with a holistic complementary range of services satisfying the customer’s expectations. We believe this is essential for reaching the market in the best possible way and to grow together with our partner,” said Dr. Javier Camargo, Global Business Development Manager, Pharmaceuticals and Nutraceuticals, Omya.

 

Dr. Tanja Schaffer, Vice President Global Pharmaceutical Industry, DKSH, added: “We are very pleased to partner with Omya for the first time in France and Spain, two of our key markets in Europe. Omya’s range of solutions are an excellent fit for our pharmaceutical and nutraceutical portfolio. We very much look forward to seeing a lot of growth opportunities with Omya going forward.”